Dec 04, 2019
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
Nov 13, 2019
Family Of USAF Soldier With Leukemia Widens Search For Bone Marrow Match
Nov 07, 2019
Partner Therapeutics (PTx) Announces the Appointment of John McManus as Chief Business Officer
Sep 24, 2019
Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
Sep 09, 2019
Grand Opening of Newly Renovated, Expanded Bone Marrow Transplant and Cellular Therapies Unit at Atrium Health's Levine Children's Hospital
Sep 06, 2019
$74.9 Bn Blood and Bone Marrow Cancer Treatment Market, 2027
Sep 05, 2019
Study Shows Stem Cells May Be Better Choice Than Tissue Transplantation for Treating LSCD
Aug 15, 2019
Soligenix Announces $150,000 NIH Small Business Innovation Research Award Supporting Evaluation of SGX942 in Pediatric Indications
Jul 23, 2019
Actinium Achieves Fifty Percent Enrollment in the Pivotal Phase 3 SIERRA Trial for Iomab-B
Jul 11, 2019
Transplant Diagnostic Market to Gain US$ 1,289.3 Million, Advances in Biomarkers for Preventing Allograft Injury Open New Directions in Industry - TMR
Jul 08, 2019
Cellect Biotechnology and Washington University (WU) Finalize Accelerated Clinical Trial Agreement
Jun 04, 2019
Actinium Presents New Pivotal Phase 3 SIERRA Trial Data Showing Rapid Peripheral Blast Reduction and Anti-Leukemic Effect with Single Agent Iomab-B in Older Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia at 2019 ASCO Annual Meeting
May 16, 2019
Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA Trial to be Presented at 2019 ASCO Annual Meeting
May 15, 2019
Apollo Proton Cancer Centre, Chennai performs India's First Total Marrow Irradiation Procedure
Apr 30, 2019
Omixon at the EFI Annual Meeting 2019
Apr 29, 2019
Bone Marrow Transplantation Market is Expected to Grow at a CAGR of 3.6% Through the Forecast Period 2018 to 2028 - Persistence Market Research
Apr 09, 2019
Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942
Mar 27, 2019
BioLineRx Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients
Mar 18, 2019
Soligenix to Present at National Institutes of Health - Commercialization Accelerator Program "FeedForward Session" in Washington, DC
Feb 25, 2019
Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019